Cannabis Market Size, Share, Trends Analysis Report, By Product Type (Flowers, Concentrates, Edibles, Topicals & Tinctures), By Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), By Application (Medical and Recreational), and By Region (North America, South America, Europe and RoW) - Industry Forecast - 2027
Cannabis Market Size, Share and Overview
From 2022 to 2027, the industrial cannabis market size is expected to rise at a remarkable compound annual growth rate (CAGR) of 24.3%. This rising trend is expected to boost market value from $27.7 billion in 2022 to $82.3 billion by the end of 2027.
Both medical and recreational cannabis industry, is currently in the center of whirl of legalization globally. The North American region dominated the global market, owing to the growing legalization trends in most of the states in the US and the increase in usage of cannabis for recreational purposes. Furthermore, growing medical applications in cannabis, rising social acceptance of cannabis, introduction of new technologies, and increase in R&D and technological innovation are expected to drive the global market for cannabis in the forecasted period.
To know about the assumptions considered for the study, Request for Free Sample Report
Cannabis Industry Growth Dynamics
Drivers: Growth in Research & Development activities and technological innovation
As the cultivation and consumption of cannabis are growing rapidly in many countries across the globe, technological innovation is also getting restructured for the efficient development of cannabis-based products. As more countries are seeking to legalize the medical use of cannabis, technological involvement is also becoming a crucial part of the development of cannabis. Traditionally, cannabis growers were mainly focused on minimal processing of the plant. However, due to technological innovations, growers are now focusing on manufacturing edibles, capsules, oils for vaping, and gummies.
Additionally, technologies like artificial intelligence, and genetic engineering are revolutionizing the cannabis industry for the good. Artificial Intelligence is big splash in the cannabis industry. With AI, growers can optimize for environmental changes and even manipulate the strains of the product. They can also adapt to the desired CBD level and change the genetic makeup of the plants to produce the types of strains that sell best. AI also aids in the efficient and timely delivery of crops. Many startups are exploring how they can use this technology to improve their ability to ship product across the country. Eaze, a California-based company, uses technology to provide cannabis deliveries via an app. They assist medical marijuana retailers in forecasting supply and demand and changing inventory and delivery based on the information by leveraging user data. Cannabase, another company, uses analytics to help businesses anticipate cannabis industry trends, price changes, and volume fluctuations. Prices in the cannabis industry are likely to fall as competition grows, making it more important than ever for businesses to use big data to gain insight into competitors, choose the right sales techniques, and target the right markets. Moreover, genetic engineering is also making its way in the industry. One such example can be of CanBreed which is performing Crispr editing to develop seeds.
Restraints: Problems associated with high-dose cannabis consumption
Legalizing cannabis has advantages in terms of expanding employment opportunities and generating more tax revenue, but it also raises the risk of cannabis overdose. Anxiety or panic attacks are some of the short-term side effects of overdosing, while heart arrhythmia and mental health issues are long-term side effects. Cannabis poisoning, or temporary negative effects from consuming too much cannabis at once, is also a possibility.
As different forms of cannabis are available such as capsules, oils, a range of different edibles and vaporizers. The edibles may pose greater risk of overdose as it takes time to show effects, which increases chances of accidentally consumption of high dose of such edibles. Also dabbing is also known to possess serious heath implication when overdone. Due to these negative health effects many countries are not legalizing cannabis and hence affecting overall cannabis industry growth.
Opportunities: Cannabis infused edibles offer better opportunities for the market growth
Robust growth in the global demand for cannabis has further propelled the need to develop better. This need has, in turn, led to several companies coming up with R&D, which extensively looks into several genetic improvement strategies for cannabis. One of the biggest opportunities for manufacturers is to produce low-dosage edible product, for consumers who want medical cannabis without psychoactive effects. In addition, low-dose edibles are a perfect product line to attract new consumers into the cannabis market since micro-dosing allows them to have control recreational consumption.
The healing benefits of cannabidiol (CBD) make it more lucrative for demand for both health and wellness objectives, and it is a significant driver driving cannabis market expansion. The CBD sector is rapidly evolving, as are CBD-infused edibles. The increased social acceptance of cannabis is driving the rise of the cannabis-infused consumable products market. The growing popularity of recreational marijuana has given rise to CBD-infused products like confectionary and bakery products. CBD oil in the edible form is in high demand. CBD oil users expect sophisticated, discrete, and appealing methods of consuming their CBD supplements, creating a plethora of options to sell CBD edibles in a variety of formats such as beverage, gummies and chocolate. Despite the fact that there are a lot of established players in the field, there is still plenty of room for smaller enterprises to establish a firm foothold. In 2018, LDN CBD, for example, created the UK's first CBD oil edibles and related items business.
Challenges: Intensive water consumption during cultivation of cannabis
Energy and consistency play a vital role in the cultivation of cannabis plants. Cannabis is one of the major energy-intensive crops grown in most states in the US and other parts of the world. A huge amount of water and light is required, along with specialized climate-control equipment for indoor and outdoor growing of plant to maximize the output. The huge water demand leads to water pollution and diversion, which could negatively impact the ecosystem. It could also directly contribute to soil erosion. However, cannabis plants have the ability to absorb as well as store heavy metals. Energy cost can add up to 50% of the wholesale price, and this percentage is expected to grow higher, owing to the continuous declining of cannabis prices. To overcome these challenges, Israel focused on innovative farming techniques that could reduce energy inputs also technologies such as precision irrigation can reduce water consumption, and application of tools such as life cycle analysis could advance the understanding of environmental impacts of cannabis cultivation.
Outdoor cultivation of cannabis is the original method of cultivation. Although with low costs, improper soil, water resources management and pest control may induce critical environmental issues. On the contrary, indoor cultivation (including greenhouse cultivation) enables full control over all these aspects, such as light and temperature, but is constrained by higher costs, energy demand, and associated environmental implications. The consistency of cannabis products plays a vital role in the production of medical applications. It is very challenging for the growers to grow large numbers of plants with the same composition. This is majorly required by the doctors for prescribing a dosage of specific cannabinoid, and need a consistent, reliable product. Furthermore, testing of cannabis also poses challenges for cannabis growers. The plant should be rigorously tested to determine the quantity of THC and CBD compound present in the plant required for medical applications. To overcome this challenge portable and remote testing system is expected to gain an important edge in the cannabis industry trends.
Cannabis Industry Highlights
- Legalization trend: The legalization of cannabis for both medical and recreational purposes is a major cannabis industry trends, leading to its growth and expansion.
- Dominance of North America: North America is the largest market for cannabis due to the legalization of cannabis in several states in the US and the high demand for recreational cannabis.
- Medical applications: The increasing use of cannabis for medical purposes, such as in the treatment of various conditions such as chronic pain, anxiety, and epilepsy, is a significant factor driving the growth of the market.
- Social acceptance: The growing social acceptance of cannabis is another important factor that is contributing to the growth of the market.
- Technological advancements: The introduction of new technologies in the cannabis industry, such as cultivation techniques and extraction methods, is leading to increased efficiency and competitiveness in the market.
- Research and development: The increasing focus on research and development in the cannabis industry growth is resulting in the development of new products and applications, which is driving the growth of the market.
Cannabis Market Report Scope
|
Report Criterion |
Details |
|
Cannabis Market Value in 2021 |
US $22.5 billion |
|
Market size value in 2022 |
US $27.7 billion |
|
Projected Market Value in 2027 |
US $82.3 billion |
|
Forecast period considered |
2022–2027 |
|
Value-based CAGR (2022-2027) |
24.3% |
|
Growing Demand |
Medical and Recreational Cannabis |
|
Units considered |
Value (USD), Volume (TONS) |
|
Segments covered |
|
|
Regions covered |
|
|
Companies studied |
|
Category wise Insights
In the Subsequent Years, the Increased Popularity of Edibles will help in the Growth of the Cannabis Business. Cannabis edibles are cannabis-infused food or drink products that have a longer, more intense effect than other cannabis products. Cannabis edibles go through a careful process when being created for consumption. To help promote the safe use of the product, the level of THC in the product must be at a safe level. For example, THC is infused into either canna-butter or canna-oil when the baked products are made. Canna-butter can be used in place of regular butter, and canna-oil can be combined with any other cooking oil.
Consumers, globally, are increasingly looking at adopting cannabis-infused products, which have been further driving food & beverage manufacturers to venture into the category. A cannabis-infused beverage is a type of THC and/or CBD-infused product that is becoming increasingly popular. They come in a variety of types, including coffee, kombucha, soft drinks, non-alcoholic beer and wine, and more, also they're easier to consume in a social setting. Molson Coors (US) has formed a joint venture with HEXO Corp (Canada), named Truss Beverages, to explore non-alcoholic cannabis infused beverages for the Canadian market. Canopy Growth Corporation (Canada), one of the leading cannabis brands in Canada, offers cannabis-infused beverage products through its brand, Tweed. According to the company, cannabis-infused chocolates are most popular in this category of products and demanded by the consumers. These market advancements are further expected to boost the cannabis industry growth for this segment during the forecast period.
Vapes are Becoming Increasingly Popular Among Marijuana Customers
Vapes are becoming increasingly popular among marijuana customers in the United States who are looking for more potent goods. For Medmen Enterprises Inc., headquartered in United States, vapes were the second-largest revenue category after flower. Vapor pen in the vapes category is a popular choice among consumers. The great bulk of vapor pen sales were made up of cartridges. Furthermore, disposable vapes are becoming increasingly popular as users seek out discreet and convenient solutions. Rising customer demand occurs despite environmental concerns, as disposable Vapes are an environmental concern, yet producers are producing them due to increased demand. Despite their popularity, vapes contribute significantly to the market's non-hazardous waste problems. Some companies and governments have taken note, and in July 2022, Fernway (US), Massachusetts' best-selling legal cannabis vape brand, launched the Fernway Recycling Program, a first-of-its-kind green initiative. The Fernway Recycling Program is the first cannabis vape hardware recycling program in Massachusetts. Customers who purchase a Fernway Traveler from a licensed dispensary can return it to the store and through its collaboration with GAIACA (US), a fully licensed, compliant cannabis waste management company, the company then coordinates the retrieval and recycling of empty Travelers.
Regional Insights
The North American Cannabis Market is Primarily Driven by Growth in the US and Canadian Markets. The year 2020 was year of opportunities and several challenges for North American cannabis industry. The US vape crisis which leads to ban and defamation of vape products in some states of US and Canada. In February 18, 2020, 2,807 individuals were hospitalized due to vaping product use-associated lung injury (EVALI) from 50 states, the District of Columbia, and two U.S. territories (Puerto Rico and U.S. Virgin Islands). Cannabis 2.0 was launched to bring a wave of growth in the industry but due to some technical issues with products and lack of consumers demand at that time, it started slow. During COVID-19 lockdown there was growth in sales of cannabis as consumer purchased it to treat their anxiety and boredom.
The US is the largest cannabis market in North America. The market has been witnessing legalization for both medical and recreational cannabis in several US states. As of 2022, 37 states and district of Columbia have approved the legal use of medical cannabis, whereas 21 have legalized the recreational or adult use of cannabis. This is majorly due to the growing awareness among consumers about the medical benefits of cannabis and a general perception of it being safer than alcohol. With the increasing number of states legalizing cannabis, it is creating several opportunities for the players operating in market. With the growth of mega-mergers, high-value investments, and sales, the industry continues to mature. Tilray (is a global pharmaceutical, cannabis-lifestyle and consumer packaged goods company) purchased Aphria (it is an international producer and distributor of medicinal and recreational cannabis) with USD 2.4 billion in April. Trulieve (it is a vertically integrated cannabis company) USD 2.3 billion acquired Harvest Health and Recreation (it operates as a medical cannabis company) in October. Several petition drives and legislative efforts for medical marijuana programs are also underway in states such as Kansas, Nebraska, North Carolina and South Carolina.
To know about the assumptions considered for the study, download the pdf brochure
Key Companies in the Cannabis Industry
Key players in cannabis market include Canopy Growth Corporation (Canada), Aurora Cannabis Inc. (Canada), VIVO Cannabis Inc. (Canada), Tilary Inc. (US), Unrivaled Brand Inc. (US), HEXO Corp. (Canada), Medical Marijuana Inc. (US), The Cronos Group (Canada), Medmen Enterprise Inc. (US), Cresco Labs (US), Curaleaf Holdings Inc. (US), Organigram Holdings Inc. (Canada), Stenocare (Denmark), Trulieve (US), and Indiva (Canada).
Target Audience:
- Cannabis growers
- Cannabis product manufacturers
- Cannabis importers and exporters
- Cannabis traders, distributors, and suppliers
- Government and research organizations
-
Associations, regulatory bodies, and other industry-related bodies:
- Food and Drug Administration (FDA)
- United States Department of Agriculture (USDA)
- Federal Institute for Drugs and Medical Devices or Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
- Bureau for Medicinal Cannabis (BMC)
- Health Canada
- Federal Commission for the Protection against Sanitary Risks (COFEPRIS)
- National Cannabis Industry Association (NCIA)
- The European Medicinal Cannabis Association (EUMCA)
- The National Association of Cannabis Businesses (NACB)
- California Cannabis Industry Association
- Australian Medical Cannabis Association
- Israel Cannabis Association (ICA)
Cannabis Market Report Segmentation
This research report categorizes the market based on product type, application, compound, and region
|
Segment |
Subsegment |
|
Market By Product Type |
|
|
Market By Application |
|
|
Market By Compound |
|
|
Market By Region |
|
Frequently Asked Questions (FAQ):
Is marijuana medicine?
The marijuana plant has compounds that may help symptoms for some health problems. While more states are making it legal to use the plant as medicine for certain conditions, scientists are still learning the ways that marijuana may help or harm people. Research on the medical use of marijuana is still in early stages, and much remains unknown about the plant and how it interacts with the body.
How big is the Cannabis Market?
In 2022, the market value stood at $27.7 billion and is anticipated to increase up to $82.3 billion by 2027.
What is growth rate of the Cannabis Market?
The global Cannabis Market is registering a growth rate CAGR of 24.3% from 2022 to 2027.
What are the key trends affecting the global cannabis market?
- Legalization Trends
- Social Acceptance
- Technological Advancements
- Medical Applications
Who are the key players in Cannabis Industry?
Aurora Cannabis Inc. (Canada), VIVO Cannabis Inc. (Canada), Tilary Inc. (US), Unrivaled Brand Inc. (US), HEXO Corp. (Canada)
Who will be the leading hub for industrial cannabis market?
North America has emerged as a leading hub for industrial cannabis market, with significant developments and applications.
What are the key opportunities in the global cannabis market?
High demand and progressive policy reforms will ensure the cannabis industry growth .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 36)
1.1 STUDY OBJECTIVES
1.2 CANNABIS MARKET DEFINITION
1.3 STUDY SCOPE
FIGURE 1 MARKET SEGMENTATION
1.3.1 INCLUSIONS AND EXCLUSIONS
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2017–2021
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 41)
2.1 RESEARCH DATA
FIGURE 2 MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 CANNABIS MARKET SIZE ESTIMATION
FIGURE 4 MARKET ESTIMATION, BY TYPE (SUPPLY-SIDE)
FIGURE 5 MARKET ESTIMATION (DEMAND-SIDE)
2.2.1 MARKET ESTIMATION: BOTTOM-UP APPROACH
FIGURE 6 MARKET ESTIMATION: BOTTOM-UP APPROACH
2.2.2 MARKET ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 7 MARKET ESTIMATION: TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION
2.4 ASSUMPTIONS
2.5 RESEARCH LIMITATIONS AND ASSOCIATED RISKS
3 EXECUTIVE SUMMARY (Page No. - 52)
TABLE 2 CANNABIS MARKET SHARE SNAPSHOT, 2022 VS. 2027 (USD MILLION)
FIGURE 9 MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 10 MARKET, BY PRODUCT TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 11 GLOBAL CANNABIS MARKET SIZE, BY COMPOUND, 2022 VS. 2027 (USD MILLION)
FIGURE 12 MARKET SHARE AND GROWTH RATE (VALUE), BY REGION, 2021
4 PREMIUM INSIGHTS (Page No. - 56)
4.1 ATTRACTIVE OPPORTUNITIES IN MARKET
FIGURE 13 GROWING MEDICINAL APPLICATIONS AND INCREASING LEGALIZATION OF CANNABIS CREATE OPPORTUNITIES IN MARKET
4.2 MARKET: MAJOR REGIONAL SUBMARKETS
FIGURE 14 NORTH AMERICA ACCOUNTED FOR LARGEST SHARE GLOBALLY IN 2021
4.3 NORTH AMERICA: S MARKET, BY COMPOUND AND COUNTRY
FIGURE 15 IN 2021, US ACCOUNTED FOR LARGEST SHARE IN NORTH AMERICA
4.4 MARKET, BY APPLICATION
FIGURE 16 RECREATIONAL SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.5 MARKET, BY COMPOUND
FIGURE 17 TETRAHYDROCANNABINOL (THC)-DOMINANT COMPOUND TO DOMINATE MARKET DURING FORECAST PERIOD
4.6 MARKET, BY PRODUCT TYPE AND REGION
FIGURE 18 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 59)
5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
5.2.1 INCREASE IN AGING POPULATION
FIGURE 19 INCREASING POPULATION OF INDIVIDUALS AGED 60 AND ABOVE (2021–2021)
5.2.2 ECONOMIC DOWNTURN
FIGURE 20 UNEMPLOYMENT AS A PERCENTAGE OF TOTAL LABOR FORCE (2010–2021)
5.3 MARKET DYNAMICS
FIGURE 21 CANNABIS MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Rising MARKET demand for medicinal applications
5.3.1.2 Legalization of cannabis and rise in social acceptance
FIGURE 22 GLOBAL MARKET REGULATORY OVERVIEW INDICATING LEGALITY OF MEDICAL RECREATIONAL CANNABIS, 2020
5.3.1.3 Growth in R&D activities and technological advancements to be precursors for cannabis business
5.3.1.4 Rising global cannabis sales helping online retailers expand
5.3.2 RESTRAINTS
5.3.2.1 Complex regulatory structure for use of cannabis
5.3.2.2 Problems associated with high dose of cannabis consumption
5.3.2.3 Stigmatization of the market
5.3.2.4 Profit margins of manufacturers shrinks as MARKET prices fall
FIGURE 23 AVERAGE SELLING PRICES OF CANNABIS, 2019–2022
5.3.3 OPPORTUNITIES
5.3.3.1 Emergence of CANNABIS MARKET legalization in Asia Pacific
5.3.3.2 Edibles, led by gummies and chocolates, to present additional growth opportunities for cannabis business
5.3.3.3 Inorganic growth strategies adopted by US cannabis companies
5.3.4 CHALLENGES
5.3.4.1 Intensive water consumption and inability to maintain consistency during cannabis cultivation
5.3.4.2 Cannabis-producing businesses face financing difficulties in US
5.3.4.3 Advertising and marketing restrictions in US
5.3.4.4 Supply chain challenges associated with cannabis in US
6 INDUSTRY TRENDS (Page No. - 73)
6.1 INTRODUCTION
6.2 VALUE CHAIN
6.2.1 RESEARCH AND PRODUCT DEVELOPMENT
6.2.2 RAW MATERIAL SOURCING
6.2.3 PRODUCTION
6.2.4 PACKAGING, STORAGE, AND DISTRIBUTION
6.2.5 RETAIL
FIGURE 24 CANNABIS MARKET: VALUE CHAIN
6.3 SUPPLY CHAIN ANALYSIS
FIGURE 25 MARKET: SUPPLY CHAIN
6.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
6.4.1 REVENUE SHIFT AND NEW REVENUE POCKETS IN MARKET
FIGURE 26 REVENUE SHIFT IMPACTING MARKET
6.5 MARKET MAPPING AND ECOSYSTEM
6.5.1 DEMAND-SIDE
6.5.2 SUPPLY-SIDE
FIGURE 27 MARKET ECOSYSTEM MAP
6.5.3 ECOSYSTEM MAP
TABLE 3 MARKET: ECOSYSTEM
6.6 TECHNOLOGY ANALYSIS
6.6.1 LED GLOW LIGHT
6.6.2 NANOENCAPSULATION
6.6.3 ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN
FIGURE 28 PROCESSES TRACKED BY USING SEED-TO-SALE TRACKER
6.6.4 CROP STEERING
6.6.5 VERTICAL FARMING
6.6.6 INNOVATIVE HARDWARE TECH DEVICES
6.6.7 IOT AUTOMATION
6.6.8 GENETIC ENGINEERING
6.7 PRICING ANALYSIS
6.7.1 SELLING PRICES CHARGED BY KEY PLAYERS IN TERMS OF PRODUCT TYPE
FIGURE 29 SELLING PRICES OF KEY PLAYERS FOR CANNABIS MARKET PRODUCT TYPE
TABLE 4 SELLING PRICE OF KEY PLAYERS FOR PRODUCT TYPE
FIGURE 30 AVERAGE SELLING PRICE IN KEY REGIONS, BY PRODUCT TYPE, 2018–2021 (USD/KG)
TABLE 5 FLOWER: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)
TABLE 6 CONCENTRATES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)
TABLE 7 EDIBLES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)
TABLE 8 TOPICALS & TINCTURES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)
TABLE 9 OTHER PRODUCT TYPES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)
6.8 CANNABIS MARKET: PATENT ANALYSIS
FIGURE 31 NUMBER OF PATENTS GRANTED FOR THE MARKET, 2011–2021
FIGURE 32 TOP PATENT APPLICANTS FOR THE MARKET, 2019–2022
FIGURE 33 REGIONAL ANALYSIS OF PATENTS GRANTED FOR MARKET, 2019–2022
6.8.1 LIST OF MAJOR PATENTS
TABLE 10 LIST OF A FEW PATENTS IN THE MARKET, 2019–2022
6.9 TRADE ANALYSIS: MARKET
6.9.1 EXPORT SCENARIO OF HEMP
FIGURE 34 HEMP EXPORT, BY KEY COUNTRY, 2017–2021 (USD THOUSAND)
TABLE 11 EXPORT DATA OF HEMP FOR KEY COUNTRIES, 2021 (VALUE AND VOLUME)
6.9.2 IMPORT SCENARIO OF HEMP
FIGURE 35 HEMP IMPORT, BY KEY COUNTRY, 2017–2021 (USD THOUSAND)
TABLE 12 IMPORT DATA OF HEMP FOR KEY COUNTRIES, 2021 (VALUE AND VOLUME)
6.10 CASE STUDIES: MARKET
6.10.1 FILTER420: ATTEMPTS TO BUILD BRAND VALUE
6.10.2 ONYX AGRONOMICS: PRECISION CANNABIS FACILITY
6.11 KEY CONFERENCES AND EVENTS, 2022–2023
TABLE 13 KEY CONFERENCES AND EVENTS IN THE CANNABIS MARKET GROWTH
6.12 TARIFF AND REGULATORY LANDSCAPE
6.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.12.2 REGULATORY FRAMEWORK
FIGURE 36 GLOBAL MARKET REGULATORY OVERVIEW INDICATING LEGALITY OF MEDICAL RECREATIONAL CANNABIS, 2022
6.12.2.1 North America
FIGURE 37 US CANNABIS REGULATORY OVERVIEW, 2022
6.12.2.1.1 US
6.12.2.1.1.1 Alaska-legalization measure approved in November 2014
6.12.2.1.1.2 Arizona-legalization measure approved in November 2020
6.12.2.1.1.3 California-legalization measure approved in November 2016
6.12.2.1.1.4 Colorado-legalization measure approved in November 2012
6.12.2.1.1.5 Connecticut-legalization measure approved in June 2021
6.12.2.1.1.6 Guam-legalization measure approved in April 2019
6.12.2.1.1.7 Illinois-legalization measure approved in May 2019
6.12.2.1.1.8 Maine-legalization measure approved in November 2016
6.12.2.1.1.9 Massachusetts-legalization measure approved in November 2016
6.12.2.1.1.10 Michigan-legalization measure approved in November 2018
6.12.2.1.1.11 Montana-legalization measure approved in January 2021
6.12.2.1.1.12 New Jersey-legalization measure approved in November 2020
6.12.2.1.1.13 New Mexico- legalization measure approved in April 2021
6.12.2.1.1.14 New York-legalization measure approved in March 2021
6.12.2.1.1.15 Oregon-legalization measure approved in November 2014
6.12.2.1.1.16 Rhode Island-legalization measure approved in May 2022
6.12.2.1.1.17 Vermont-legalization measure approved in January 2018
6.12.2.1.1.18 Virginia-legalization measure approved in April 2021
6.12.2.1.1.19 Washington-legalization measure approved in November 2012
6.12.2.1.2 Canada
6.12.2.2 Europe
6.12.2.2.1 German-legalization measure approved in 2017
6.12.2.2.2 Italy-legalization measure approved in 2014
6.12.2.2.3 Denmark-legalization measure approved in January 2018
6.12.2.2.4 Malta-legalization measure approved in January 2018
6.12.2.2.5 Netherlands-legalization measure approved in January 2013
6.12.2.2.6 France-legalization measure approved in March 2022
6.12.2.2.7 Switzerland
6.12.2.2.8 UK
6.12.2.2.9 Belgium
6.12.2.2.10 Poland
6.12.2.2.11 Czech Republic
6.12.2.2.12 Spain
6.12.2.2.13 Austria
6.12.2.2.14 Norway
6.12.2.2.15 Finland
6.12.2.2.16 Croatia
6.12.2.3 South America
6.12.2.3.1 Chile-legalization measure approved in 2015
6.12.2.3.2 Colombia-legalization measure approved in 2015
6.12.2.3.3 Uruguay-legalization measure approved in December 2013
6.12.2.4 Rest of the world
6.12.2.4.1 Israel-legalization measure approved in December 2018
6.12.2.4.2 Australia-legalization measure approved in February 2016
6.12.2.4.3 Thailand
6.12.2.4.4 South Korea
6.12.2.4.5 Malaysia
6.12.2.4.6 South Africa
6.13 PORTER’S FIVE FORCES ANALYSIS
TABLE 18 CANNABIS MARKET REPORT: PORTER’S FIVE FORCES ANALYSIS
6.13.1 DEGREE OF COMPETITION
6.13.2 BARGAINING POWER OF SUPPLIERS
6.13.3 BARGAINING POWER OF BUYERS
6.13.4 THREAT OF SUBSTITUTES
6.13.5 THREAT OF NEW ENTRANTS
6.14 KEY STAKEHOLDERS AND BUYING CRITERIA
6.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 38 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP APPLICATIONS
TABLE 19 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP APPLICATIONS (%)
6.14.2 BUYING CRITERIA
FIGURE 39 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR
TABLE 20 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR
7 CANNABIS MARKET FORECAST, BY PRODUCT TYPE (Page No. - 110)
7.1 INTRODUCTION
FIGURE 40 MARKET SHARE (VALUE), BY PRODUCT TYPE, 2022 VS 2027
TABLE 21 MARKET, BY PRODUCT TYPE, 2018–2021 (USD MILLION)
TABLE 22 MARKET, BY PRODUCT TYPE, 2022–2027 (USD MILLION)
TABLE 23 MARKET, BY PRODUCT TYPE, 2018–2021 (TONS)
TABLE 24 MARKET, BY PRODUCT TYPE, 2022–2027 (TONS)
7.2 FLOWERS
7.2.1 AUTOMATION AND SUSTAINABLE PACKAGING TO BE KEY TRENDS IN PRE-ROLL DOMAIN
TABLE 25 FLOWERS: MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 26 FLOWERS: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 27 FLOWERS: MARKET, BY REGION, 2018–2021 (TONS)
TABLE 28 FLOWERS: MARKET SIZE, BY REGION, 2022–2027 (TONS)
7.3 CONCENTRATES
7.3.1 VARIOUS DELIVERY METHODS RESULTED IN CONSUMER-FRIENDLY CANNABIS CONCENTRATES MARKET
TABLE 29 CONCENTRATES: MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 30 CONCENTRATES: MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 31 CONCENTRATES: MARKET, BY REGION, 2018–2021 (TONS)
TABLE 32 CONCENTRATES: MARKET SIZE, BY REGION, 2022–2027 (TONS)
7.4 EDIBLES
7.4.1 FOOD AND BEVERAGE MANUFACTURING COMPANIES VENTURE INTO CANNABIS-INFUSED EDIBLES
TABLE 33 EDIBLES: MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 34 EDIBLES: MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 35 EDIBLES: MARKET, BY REGION, 2018–2021 (TONS)
TABLE 36 EDIBLES: MARKET SIZE, BY REGION, 2022–2027 (TONS)
7.5 TOPICALS & TINCTURES
7.5.1 TOPICALS WITNESS INCREASED DEMAND IN SKINCARE INDUSTRY
TABLE 37 TOPICALS & TINCTURES: MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 38 TOPICALS & TINCTURES: MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 39 TOPICALS & TINCTURES: MARKET, BY REGION, 2018–2021 (TONS)
TABLE 40 TOPICALS & TINCTURES: MARKET SIZE, BY REGION, 2022–2027 (TONS)
7.6 OTHER PRODUCT TYPES
TABLE 41 OTHER PRODUCT TYPES: MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 42 OTHER PRODUCT TYPES: MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 43 OTHER PRODUCT TYPES: MARKET, BY REGION, 2018–2021 (TONS)
TABLE 44 OTHER PRODUCT TYPES: MARKET SIZE, BY REGION, 2022–2027 (TONS)
8 CANNABIS MARKET GROWTH, BY COMPOUND (Page No. - 125)
8.1 INTRODUCTION
FIGURE 41 MARKET SHARE (VALUE), BY COMPOUND, 2022 VS 2027
TABLE 45 MARKET, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 46 MARKET, BY COMPOUND, 2022–2027 (USD MILLION)
8.2 TETRAHYDROCANNABINOL (THC)-DOMINANT
8.2.1 INCREASING LEGALIZATION OF RECREATIONAL CANNABIS PROPELS THC-DOMINANT MARKET
TABLE 47 THC-DOMINANT: MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 48 THC-DOMINANT: MARKET, BY REGION, 2022–2027 (USD MILLION)
8.3 CANNABIDIOL (CBD)-DOMINANT
8.3.1 INCREASED POPULARITY OF CBD EDIBLES TO DRIVE CBD-DOMINANT MARKET
TABLE 49 CBD-DOMINANT: MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 50 CBD-DOMINANT: MARKET, BY REGION, 2022–2027 (USD MILLION)
8.4 BALANCED THC & CBD
8.4.1 BALANCED THC & CBD STRAINS WITNESS GROWTH AS CBD DIMINISHES PSYCHOACTIVE PROPERTIES OF THC
TABLE 51 BALANCED THC & CBD: MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 52 BALANCED THC & CBD: MARKET, BY REGION, 2022–2027 (USD MILLION)
9 CANNABIS MARKET FORECAST, BY APPLICATION (Page No. - 131)
9.1 INTRODUCTION
FIGURE 42 MARKET SHARE (VALUE), BY APPLICATION, 2022 VS 2027
TABLE 53 MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 54 MARKET, BY APPLICATION, 2022–2027 (USD MILLION)
9.2 MEDICAL
9.2.1 INCREASE IN MARKET USE FOR TREATMENT OF VARIOUS AILMENTS DRIVES DEMAND FOR MEDICAL CANNABIS
9.2.1.1 Pain management
9.2.1.2 Neurological health management
9.2.1.3 Mental health management
9.2.1.4 Other medical applications
TABLE 55 MEDICAL: MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 56 MEDICAL: MARKET, BY REGION, 2022–2027 (USD MILLION)
9.3 RECREATIONAL
9.3.1 WIDER LEGALIZATION STATUS OF RECREATIONAL CANNABIS TO BOOST MARKET GROWTH
TABLE 57 RECREATIONAL: MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 58 RECREATIONAL: MARKET, BY REGION, 2022–2027 (USD MILLION)
10 CANNABIS, BY REGION (Page No. - 140)
10.1 INTRODUCTION
FIGURE 43 REGIONAL SNAPSHOT: NEW HOTSPOTS TO EMERGE IN EUROPE, 2022–2027
TABLE 59 GLOBAL CANNABIS MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
TABLE 60 MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 61 MARKET SIZE, BY REGION, 2018–2021 (TONS)
TABLE 62 MARKET SIZE, BY REGION, 2022–2027 (TONS)
10.2 NORTH AMERICA
FIGURE 44 NORTH AMERICA: MARKET SNAPSHOT
TABLE 63 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 64 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 65 NORTH AMERICA: MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 66 NORTH AMERICA: MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)
TABLE 67 NORTH AMERICA: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 68 NORTH AMERICA: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
TABLE 69 NORTH AMERICA: MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)
TABLE 70 NORTH AMERICA: MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)
TABLE 71 NORTH AMERICA: MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)
TABLE 72 NORTH AMERICA: MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)
10.2.1 US
10.2.1.1 Increase in mergers, investments, and sales drive market in US
TABLE 73 US: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 74 US: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Presence of major players in Canada boosts growth during forecast period
TABLE 75 CANADA: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 76 CANADA: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.2.3 MEXICO
10.2.3.1 Medical cannabis used for epilepsy treatment boosts Mexican market growth
TABLE 77 MEXICO: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 78 MEXICO: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.3 EUROPE
FIGURE 45 EUROPE: MARKET SNAPSHOT
TABLE 79 EUROPE: MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 80 EUROPE: MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 81 EUROPE: MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 82 EUROPE: MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)
TABLE 83 EUROPE: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 84 EUROPE: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
TABLE 85 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)
TABLE 86 EUROPE: MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)
TABLE 87 EUROPE: MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)
TABLE 88 EUROPE: MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)
10.3.1 GERMANY
10.3.1.1 Health insurance coverage for cannabis use in medical treatments driving market
TABLE 89 GERMANY: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 90 GERMANY: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.3.2 ITALY
10.3.2.1 Increase in demand for cannabis and issuance of import licenses to drive market
TABLE 91 ITALY: MARKET, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 92 ITALY: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.3.3 DENMARK
10.3.3.1 Huge demand for medical cannabis to drive Danish medical market
TABLE 93 DENMARK: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 94 DENMARK: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.3.4 NETHERLANDS
10.3.4.1 Strong infrastructure and rise in export of medical cannabis to other countries drive market
TABLE 95 NETHERLANDS: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 96 NETHERLANDS: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.3.5 FRANCE
10.3.5.1 Government providing finance to healthcare systems and refunds provided to patients
TABLE 97 FRANCE: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 98 FRANCE: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 99 REST OF EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 100 REST OF EUROPE: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.4 SOUTH AMERICA
TABLE 101 SOUTH AMERICA: MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 102 SOUTH AMERICA: MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 103 SOUTH AMERICA: MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 104 SOUTH AMERICA: MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)
TABLE 105 SOUTH AMERICA: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 106 SOUTH AMERICA: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
TABLE 107 SOUTH AMERICA: MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)
TABLE 108 SOUTH AMERICA: MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)
TABLE 109 SOUTH AMERICA: MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)
TABLE 110 SOUTH AMERICA: MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)
10.4.1 CHILE
10.4.1.1 Rise in consumption of cannabis for medical usage driving cannabis market report
TABLE 111 CHILE: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 112 CHILE: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.4.2 COLOMBIA
10.4.2.1 Increased cannabis license distribution to companies drives market
TABLE 113 COLOMBIA: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 114 COLOMBIA: MARKETSIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.4.3 URUGUAY
10.4.3.1 Fully legalized cannabis industry with eased regulations drives market
TABLE 115 URUGUAY: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 116 URUGUAY: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.4.4 REST OF SOUTH AMERICA
TABLE 117 REST OF SOUTH AMERICA: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
FALSE
10.5 ROW
TABLE 119 ROW: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 120 ROW: MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 121 ROW: MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 122 ROW: MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)
TABLE 123 ROW: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 124 ROW: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
TABLE 125 ROW: MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)
TABLE 126 ROW: MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)
TABLE 127 ROW: MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)
TABLE 128 ROW: MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)
10.5.1 ISRAEL
10.5.1.1 Technical innovations and increased exports to drive market
TABLE 129 ISRAEL: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 130 ISRAEL: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.5.2 AUSTRALIA
10.5.2.1 Surge in epilepsy, chronic pain, and cancer patients resulted in market growth
TABLE 131 AUSTRALIA: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 132 AUSTRALIA: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.5.3 OTHERS IN ROW
TABLE 133 OTHERS IN ROW: MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 134 OTHERS IN ROW: MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 176)
11.1 OVERVIEW
11.2 CANNABIS MARKET SHARE ANALYSIS, 2021
TABLE 135 MARKET: DEGREE OF COMPETITION (FRAGMENTED)
11.3 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS
FIGURE 46 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS IN MARKET, 2017–2021 (USD MILLION)
11.4 KEY PLAYER STRATEGIES
TABLE 136 STRATEGIES ADOPTED BY KEY CANNABIS MANUFACTURERS
11.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS)
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 47 MARKET: COMPANY EVALUATION QUADRANT, 2021 (KEY PLAYERS)
11.5.5 PRODUCT FOOTPRINT
TABLE 137 COMPANY FOOTPRINT, BY APPLICATION
TABLE 138 COMPANY FOOTPRINT, BY TYPE
TABLE 139 COMPANY FOOTPRINT, BY REGION
TABLE 140 OVERALL COMPANY FOOTPRINT
11.6 MARKET: EVALUATION QUADRANT FOR STARTUPS/SMES, 2021
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 48 MARKET: COMPANY EVALUATION QUADRANT, 2021 (STARTUPS/SMES)
11.6.5 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 141 MARKET: DETAILED LIST OF KEY STARTUP/SMES
TABLE 142 CANNABIS MARKET FORECAST: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
11.7 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS
11.7.1 PRODUCT LAUNCHES
TABLE 143 CANNABIS: PRODUCT LAUNCHES, 2019–2022
11.7.2 DEALS
TABLE 144 CANNABIS: DEALS, 2019–2022
11.7.3 OTHERS
TABLE 145 CANNABIS: OTHERS, 2019–2022
12 COMPANY PROFILES (Page No. - 193)
12.1 INTRODUCTION
12.2 KEY PLAYER
(Business overview, Products/Solutions/Services offered, Recent developments, New product launches, Deals, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats)*
12.2.1 CANOPY GROWTH CORPORATION
TABLE 146 CANOPY GROWTH CORPORATION: BUSINESS OVERVIEW
FIGURE 49 CANOPY GROWTH CORPORATION: COMPANY SNAPSHOT
TABLE 147 CANOPY GROWTH CORPORATION: PRODUCTS OFFERED
TABLE 148 CANOPY GROWTH CORPORATION: NEW PRODUCT LAUNCHES
TABLE 149 CANOPY GROWTH CORPORATION: DEALS
TABLE 150 CANOPY GROWTH CORPORATION: OTHERS
12.2.2 CURALEAF
TABLE 151 CURALEAF: BUSINESS OVERVIEW
FIGURE 50 CURALEAF: COMPANY SNAPSHOT
TABLE 152 CURALEAF: PRODUCTS OFFERED
TABLE 153 CURALEAF: NEW PRODUCT LAUNCHES
TABLE 154 CURALEAF: DEALS
TABLE 155 CURALEAF: OTHERS
12.2.3 CRESCO LABS
TABLE 156 CRESCO LABS: CANNABIS MARKET BUSINESS OVERVIEW
FIGURE 51 CRESCO LABS: COMPANY SNAPSHOT
TABLE 157 CRESCO LABS: PRODUCTS OFFERED
TABLE 158 CRESCO LABS: NEW PRODUCT LAUNCHES
TABLE 159 CRESCO LABS: DEALS
TABLE 160 CRESCO LABS: OTHERS
12.2.4 GREEN THUMB INDUSTRIES
TABLE 161 GREEN THUMB INDUSTRIES: BUSINESS OVERVIEW
FIGURE 52 GREEN THUMB INDUSTRIES: COMPANY SNAPSHOT
TABLE 162 GREEN THUMB INDUSTRIES: PRODUCTS OFFERED
TABLE 163 GREEN THUMB INDUSTRIES: DEALS
TABLE 164 GREEN THUMB INDUSTRIES: OTHERS
12.2.5 TILRAY
TABLE 165 TILRAY: BUSINESS OVERVIEW
FIGURE 53 TILRAY: COMPANY SNAPSHOT
TABLE 166 TILRAY INC: PRODUCTS OFFERED
TABLE 167 TILRAY: NEW PRODUCT LAUNCHES
TABLE 168 TILRAY: DEALS
TABLE 169 TILRAY: OTHERS
12.2.6 TRULIEVE
TABLE 170 TRULIEVE: BUSINESS OVERVIEW
FIGURE 54 TRULIEVE: COMPANY SNAPSHOT
TABLE 171 TRULIEVE: PRODUCTS OFFERED
TABLE 172 TRULIEVE: DEALS
TABLE 173 TRULIEVE: OTHERS
12.2.7 AURORA CANNABIS INC.
TABLE 174 AURORA CANNABIS INC.: CANNABIS MARKET BUSINESS OVERVIEW
FIGURE 55 AURORA CANNABIS INC.: COMPANY SNAPSHOT
TABLE 175 AURORA CANNABIS INC.: PRODUCTS OFFERED
TABLE 176 AURORA CANNABIS INC.: NEW PRODUCT LAUNCHES
TABLE 177 AURORA CANNABIS INC.: DEALS
TABLE 178 AURORA CANNABIS INC.: OTHERS
12.2.8 MEDMEN
TABLE 179 MEDMEN: BUSINESS OVERVIEW
FIGURE 56 MEDMEN: COMPANY SNAPSHOT
TABLE 180 MEDMEN: PRODUCTS OFFERED
TABLE 181 MEDMEN: OTHERS
12.2.9 UNRIVALED BRAND INC.
TABLE 182 UNRIVALED BRAND INC.: BUSINESS OVERVIEW
FIGURE 57 UNRIVALED BRAND INC.: COMPANY SNAPSHOT
TABLE 183 UNRIVALED BRAND INC.: PRODUCTS OFFERED
TABLE 184 UNRIVALED BRAND INC.: DEALS
TABLE 185 UNRIVALED BRAND INC.: OTHERS
12.2.10 ORGANIGRAM HOLDINGS INC.
TABLE 186 ORGANIGRAM HOLDINGS INC.: BUSINESS OVERVIEW
FIGURE 58 ORGANIGRAM HOLDINGS INC.: COMPANY SNAPSHOT
TABLE 187 ORGANIGRAM HOLDINGS INC.: PRODUCTS OFFERED
TABLE 188 ORGANIGRAM HOLDINGS INC.: PRODUCT LAUNCH
TABLE 189 ORGANIGRAM HOLDINGS INC.: DEALS
TABLE 190 ORGANIGRAM HOLDINGS INC.: OTHERS
12.2.11 STENOCARE
TABLE 191 STENOCARE: BUSINESS OVERVIEW
FIGURE 59 STENOCARE: COMPANY SNAPSHOT
TABLE 192 STENOCARE: PRODUCTS OFFERED
TABLE 193 STENOCARE: DEALS
TABLE 194 STENOCARE: OTHERS
12.2.12 VIVO CANNABIS INC.
TABLE 195 VIVO CANNABIS INC.: CANNABIS MARKET BUSINESS OVERVIEW
FIGURE 60 VIVO CANNABIS INC.: COMPANY SNAPSHOT
TABLE 196 VIVO CANNABIS INC.: PRODUCTS OFFERED
TABLE 197 VIVO CANNABIS INC.: NEW PRODUCT LAUNCHES
TABLE 198 VIVO CANNABIS INC.: DEALS
TABLE 199 VIVO CANNABIS INC.: OTHERS
12.2.13 TERRASCEND
TABLE 200 TERRASCEND: BUSINESS OVERVIEW
FIGURE 61 TERRASCEND: COMPANY SNAPSHOT
TABLE 201 TERRASCEND: PRODUCTS OFFERED
TABLE 202 TERRASCEND: DEALS
TABLE 203 TERRASCEND: OTHERS
12.2.14 HEXO CORP
TABLE 204 HEXO CORP: BUSINESS OVERVIEW
FIGURE 62 HEXO CORP: COMPANY SNAPSHOT
TABLE 205 HEXO CORP: PRODUCTS OFFERED
TABLE 206 HEXO CORP: NEW PRODUCT LAUNCHES
TABLE 207 HEXO CORP: DEALS
TABLE 208 HEXO CORP: OTHERS
12.2.15 VILLAGE FARMS INTERNATIONAL INC.
TABLE 209 VILLAGE FARMS INTERNATIONAL INC.: BUSINESS OVERVIEW
FIGURE 63 VILLAGE FARMS INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 210 VILLAGE FARMS INTERNATIONAL INC.: PRODUCTS OFFERED
TABLE 211 VILLAGE FARMS INTERNATIONAL INC.: OTHERS
12.2.16 VERANO
TABLE 212 VERANO: BUSINESS OVERVIEW
FIGURE 64 VERANO: COMPANY SNAPSHOT
TABLE 213 VERANO: PRODUCTS OFFERED
TABLE 214 VERANO: DEALS
TABLE 215 VERANO: OTHERS
12.3 OTHER PLAYERS (SMES/STARTUPS)
12.3.1 THE CRONOS GROUP
TABLE 216 THE CRONOS GROUP: BUSINESS OVERVIEW
FIGURE 65 THE CRONOS GROUP: COMPANY SNAPSHOT
TABLE 217 THE CRONOS GROUP: PRODUCTS OFFERED
TABLE 218 THE CRONOS GROUP: DEALS
TABLE 219 THE CRONOS GROUP: OTHERS
12.3.2 MEDICAL MARIJUANA, INC.
TABLE 220 MEDICAL MARIJUANA, INC.: BUSINESS OVERVIEW
FIGURE 66 MEDICAL MARIJUANA, INC.: COMPANY SNAPSHOT
TABLE 221 MEDICAL MARIJUANA, INC.: PRODUCTS OFFERED
TABLE 222 MEDICAL MARIJUANA, INC.: NEW PRODUCT LAUNCHES
TABLE 223 MEDICAL MARIJUANA, INC.: DEALS
TABLE 224 MEDICAL MARIJUANA, INC.: OTHERS
12.3.3 ECOFIBRE LIMITED
TABLE 225 ECOFIBRE LIMITED: CANNABIS MARKET BUSINESS OVERVIEW
FIGURE 67 ECOFIBRE LIMITED: COMPANY SNAPSHOT
TABLE 226 ECOFIBRE LIMITED: PRODUCTS OFFERED
TABLE 227 ECOFIBRE LIMITED: OTHERS
12.3.4 INDIVA
TABLE 228 INDIVA: BUSINESS OVERVIEW
FIGURE 68 INDIVA: COMPANY SNAPSHOT
TABLE 229 INDIVA: PRODUCTS OFFERED
TABLE 230 INDIVA: NEW PRODUCT LAUNCHES
TABLE 231 INDIVA: DEALS
TABLE 232 INDIVA: OTHERS
12.3.5 TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.
TABLE 233 TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.: BUSINESS OVERVIEW
TABLE 234 TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.: PRODUCTS OFFERED
12.3.6 MARICANN GROUP INC
TABLE 235 MARICANN GROUP INC: BUSINESS OVERVIEW
TABLE 236 MARICANN GROUP INC: PRODUCTS OFFERED
12.3.7 SATIPHARM
12.3.8 CANNABLISS ORGANIC LLC
12.3.9 CONNECTED CANNABIS CO.
12.3.10 JUSTICE CANNABIS CO.
12.3.11 HENRY'S ORIGINAL
*Details on Business overview, Products/Solutions/Services offered, Recent developments, New product launches, Deals, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 290)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATIONS OFFERED
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This research involves the extensive use of secondary sources; directories; and databases, such as the Food and Drug Administration (FDA), Bureau for Medicinal Cannabis (BMC), National Cannabis Industry Association (NCIA), The European Medicinal Cannabis Association (EUMCA), Bloomberg, and Factiva, to identify and collect information useful for a technical, market-oriented, and commercial study of the cannabis market overview. In-depth interviews were conducted with various primary respondents, such as key industry participants, Subject Matter Experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess prospects.
Secondary Research
In the secondary research process, various sources, such as the Food and Drug Administration (FDA), Bureau for Medicinal Cannabis (BMC), National Cannabis Industry Association (NCIA), The European Medicinal Cannabis Association (EUMCA), were referred to identify and collect information for this study. The secondary sources also include medical journals, press releases, investor presentations of companies, white papers, certified publications, articles by recognized authors and regulatory bodies, trade directories, and paid databases.
Secondary research was mainly conducted to obtain critical information about the industry’s supply chain, the total pool of key players, and market classification & segmentation according to the industry trends to the bottom-most level and geographical markets. It was also used to obtain information about the key developments from a market-oriented perspective.
Primary Research
The cannabis industry overview comprises several stakeholders, including cannabis growers, end-product manufacturers, and regulatory organizations in the supply chain. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Primary interviewees from the supply-side include research institutions involved in R&D to introduce technology, distributors, wholesalers, importers & exporters of cannabis manufacturers and technology providers. Primary sources from the demand-side include key opinion leaders, executives, vice presidents, and CEOs through questionnaires, emails, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Cannabis Market Size Estimation
Both the top-down and bottom-up approaches have been used to estimate and validate the total cannabis market size. These approaches were extensively used to determine the size of the subsegments in the market. The research methodology used to estimate the market size includes the following details:
-
Top-down approach:
- The key industry and market players were identified through extensive secondary research.
- The industry's supply chain and market size were determined through primary and secondary research.
- All percentage share splits and breakdowns were determined using secondary sources and verified through primary sources.
- The peer market—the cannabis devices market—was considered to validate further the market details of cannabis.
-
Bottom-up approach:
- The market sizes were analyzed based on the share of each type of cannabis at regional and country levels. Thus, the global market was estimated with a bottom-up approach of the type at the country level.
- Other factors include the penetration rate of cannabis in distinguished product types, such as edibles, flowers, concentrates; consumer awareness; and function trends; pricing trends; the adoption rate and price factors; patents registered; and organic and inorganic growth attempts.
- All macroeconomic and microeconomic factors affecting the cannabis industry were considered while estimating the market size.
- All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.
Data Triangulation
After arriving at the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to estimate the overall cannabis industry trends and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.
Report Objectives
- To define, segment, and project the global cannabis market statistics on the basis of product type, application, compound, and region
- To provide detailed information regarding the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and their contribution to the total market
- To analyze the opportunities in the market for stakeholders and provide a competitive landscape of the market leaders
- To project the size of the market and its submarkets, in terms of value with respect to the regions (along with the key countries)
- To strategically profile the key players and comprehensively analyze their market position and core competencies
- To analyze the competitive developments such as joint ventures, mergers & acquisitions, new product developments, and research & developments in market
Available Customizations:
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
The following customization options are available for the report:
Product Analysis
- Product Matrix, which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
With the given market data, MarketsandMarkets offers customizations according to the company-specific scientific needs.
- Further breakdown of the Rest of European cannabis market share, by key country
- Further breakdown of the Rest of South America, by key country
Company Information
- Detailed analyses and profiling of additional market players
Generating Response ...
Growth opportunities and latent adjacency in Cannabis Market